Shane Cooke

Shane Cooke serves as the President of Alkermes, bringing extensive experience and leadership to the role. Under Shane Cooke's guidance, Alkermes focuses on innovative solutions in the pharmaceutical industry, working towards advancements in treatment options for patients with serious mental health conditions and addiction. Shane Cooke's strategic vision and commitment to improving patient outcomes have significantly impacted the company's direction and success.